Table 2.
Final model results (N = 240)
| β | b | SE(b) | b/SE | p | |
|---|---|---|---|---|---|
| Functional health | |||||
| General health | .83 | 1.00 | – | – | – |
| Physical functioning | .51 | .82 | .15 | 5.51 | <.001 |
| HIV symptoms | .33 | .07 | .02 | 3.85 | <.001 |
| Depression | |||||
| CES-D | .86 | 1.00 | – | – | – |
| MADRS | .62 | .60 | .07 | 8.99 | <.001 |
| BADS | .76 | 2.02 | .19 | 10.44 | <.001 |
| Functional health on | |||||
| Depression | − .59 | − 1.17 | .18 | − 6.42 | <.001 |
| Substance use | − .05 | − .49 | .74 | − .67 | .502 |
| Age | − .15 | − .30 | .14 | − 2.17 | .030 |
| ART adherence | .16 | 1.23 | .54 | 2.27 | .023 |
| Depression on | |||||
| Stress | .15 | .64 | .31 | 2.08 | .038 |
| Stigma | .16 | 1.52 | .66 | 2.29 | .022 |
| Substance use on | |||||
| Stress | − .02 | − .01 | .05 | − .26 | .795 |
| Stigma | − .04 | −.07 | .11 | − .62 | .538 |
| Functional health on stress | |||||
| via depression | − .09 | − .74 | .37 | − 2.01 | .045 |
| via substance use | .00 | .01 | .03 | .24 | .808 |
| Total effect | − .09 | − 1.74 | .80 | − 2.16 | .030 |
| Functional health on stigma | |||||
| via depression | − .10 | − 1.77 | .80 | − 2.21 | .027 |
| via substance use | .00 | .03 | .08 | .45 | .650 |
| Total effect | − .09 | − .74 | .37 | − 1.98 | .047 |
| MADRS with HIV symptoms | − .27 | − 5.73 | 1.55 | − 3.69 | <.001 |
| BADS with general health | .26 | 43.77 | 20.54 | 2.12 | .033 |
χ2(33) = 41.86, p = .139; CFI = .98; RMSEA = .034